A double‐blind, placebo‐controlled study of the efficacy and safety of non‐prescription ranitidine 75 mg in the prevention of meal‐induced heartburn
Authors:
- 1 April 1999
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 13 (4) , 467-473
Abstract
Ranitidine 75 mg (Zantac 75) has been shown to be effective for the treatment of pre-existing heartburn symptoms. To compare the efficacy of dosing ranitidine 75 mg or placebo 30 min prior to a proven heartburn-provoking meal in completely preventing or reducing subsequent heartburn symptoms. A randomized, double-blind, parallel methodology was used at nine investigative centres. Following a screening visit, patients ate a standard test meal consisting of chili, chips and a soft drink on two occasions. On the first occasion, patients received single-blind placebo 30 min before the meal. This meal was used to qualify patients and to ensure the onset of a minimum level of heartburn. Patients who qualified were randomized (n = 284) to receive double-blind ranitidine 75 mg or placebo 30 min before a second test meal administered 4-14 days later at the treatment visit. Patients recorded whether heartburn was present and rated heartburn severity by completing visual analogue scales at 15-min intervals over the 4. 5 h meal evaluation periods. Statistically significant differences favouring ranitidine 75 mg were determined for complete prevention of heartburn (P < 0.006), heartburn severity area under the curve (P < 0.001), a clinical success end-point (P < 0.001), and all other end-points (P < 0.001). These data clearly demonstrate that ranitidine 75 mg is effective in completely preventing or decreasing heartburn when administered 30 min prior to a provocative meal.Keywords
This publication has 16 references indexed in Scilit:
- A double-masked, placebo-controlled study of the efficacy and safety of premeal ranitidine in the prevention or reduction of heartburnCurrent Therapeutic Research, 1998
- The impact of over-the-counter histamine-2-antagonists: Great expectations unfulfilledGastroenterology, 1998
- The effects of low doses of ranitidine on intragastric acidity in healthy menAlimentary Pharmacology & Therapeutics, 1998
- Prevention of heartburn relapse by low‐dose famotidine: a test meal model for duration of symptom controlAlimentary Pharmacology & Therapeutics, 1997
- How Does Chili Cause Upper Gastrointestinal Symptoms?Journal of Clinical Gastroenterology, 1995
- EFFICACY AND TOLERABILITY OF FAMOTIDINE IN PREVENTING HEARTBURN AND RELATED SYMPTOMS OF UPPER GASTROINTESTINAL DISCOMFORTAmerican Journal of Therapeutics, 1995
- The Prevalence of Symptoms Suggestive of Esophageal DisordersScandinavian Journal of Gastroenterology, 1991
- Effectiveness of Foaming Antacid in Relieving Induced HeartburnSouthern Medical Journal, 1986
- Mechanisms of Gastroesophageal Reflux in Patients with Reflux EsophagitisNew England Journal of Medicine, 1982
- Symptomatic gastroesophageal reflux: Incidence and precipitating factorsDigestive Diseases and Sciences, 1976